NBTX Nanobiotix S.A.
Healthcare$41.01+2.07%ClosedMarket Cap: $1.98B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-20.57
P/S
59.80
EV/EBITDA
-150.41
DCF Value
$-3.83
FCF Yield
-1.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-36.5%
Net Margin
-80.8%
ROE
31.2%
ROA
-35.4%
ROIC
-74.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $3.0M | 100.0% | $-11.6M | $-18.6M | $— | — |
| FY null | $29.6M | 100.0% | $-10.8M | $-24.0M | $— | — |
| Q2 null | $26.6M | 100.0% | $808.0K | $-5.4M | $— | — |
| Q4 null | $-16.5M | 100.0% | $-44.7M | $-46.3M | $— | — |
| FY null | $-7.2M | 100.0% | $-68.4M | $-68.1M | $— | — |
| Q2 null | $9.3M | 100.0% | $-23.7M | $-21.9M | $— | — |
| Q4 null | $32.9M | 100.0% | $-1.4M | $-11.6M | $— | — |
| FY null | $36.2M | 100.0% | $-26.8M | $-39.7M | $— | — |
| Q2 null | $3.3M | 100.0% | $-25.4M | $-28.1M | $— | — |
| Q4 null | $3.4M | 100.0% | $-20.8M | $-30.7M | $— | — |
| FY null | $4.8M | 100.0% | $-46.7M | $-57.0M | $— | — |
| Q2 null | $1.3M | 100.0% | $-25.9M | $-26.4M | $— | — |